Showing results (841-850 of 967) with videos related to

Sort By:
Pageof 97
Atherosclerosis|August 16, 2025
Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trialSatoshi Kitahara, Yu Kataoka, Stephen J Nicholls, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2020
Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinibToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
JACC. Asia|October 1, 2025
Risk Prediction Models of Cardiotoxicity in Patients With Breast Cancer: Multicenter Prospective CHECK HEART-BC StudyYosuke Terui, Kotaro Nochioka, Hideki Ota, et al.
Thrombosis and Haemostasis|November 10, 2020
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular DiseaseHyun Kuk Kim, Udaya S Tantry, Sidney C Smith, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in JapanTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
Liver Cancer|May 12, 2021
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 22, 2017
Long-Term Outcomes of Non-ST-Elevation Myocardial Infarction Without Creatine Kinase Elevation - The J-MINUET StudyMasaharu Ishihara, Koichi Nakao, Yukio Ozaki, et al.
Scientific Reports|July 15, 2021
Impact of modified albumin-bilirubin grade on survival in patients with HCC who received lenvatinibToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Journal of Gastroenterology and Hepatology|November 10, 2020
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weightingAtsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, et al.
Pageof 97